Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2003 | 4 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab in B-cell chronic lymphocytic leukemia.
Semin Oncol. 2003 Aug;30(4):483-92. doi: 10.1016/s0093-7754(03)00239-2.
Semin Oncol. 2003.
PMID: 12939717
Review.
Antibody therapy of acute and chronic leukemias.
Cataland SR, Lucas M, Byrd JC.
Cataland SR, et al.
Curr Pharm Biotechnol. 2001 Dec;2(4):357-67. doi: 10.2174/1389201013378608.
Curr Pharm Biotechnol. 2001.
PMID: 11762417
Review.
Item in Clipboard
Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.
Bannerji R, Kitada S, Flinn IW, Pearson M, Young D, Reed JC, Byrd JC.
Bannerji R, et al.
J Clin Oncol. 2003 Apr 15;21(8):1466-71. doi: 10.1200/JCO.2003.06.012.
J Clin Oncol. 2003.
PMID: 12697868
Item in Clipboard
Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab.
Byrd JC, Smith L, Hackbarth ML, Flinn IW, Young D, Proffitt JH, Heerema NA.
Byrd JC, et al.
Cancer Res. 2003 Jan 1;63(1):36-8.
Cancer Res. 2003.
PMID: 12517774
Item in Clipboard
KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis.
Byrd JC, Lucas DM, Mone AP, Kitner JB, Drabick JJ, Grever MR.
Byrd JC, et al.
Blood. 2003 Jun 1;101(11):4547-50. doi: 10.1182/blood-2002-08-2623. Epub 2003 Feb 20.
Blood. 2003.
PMID: 12595316
Free article.
Item in Clipboard
Cite
Cite